141 related articles for article (PubMed ID: 2174971)
1. Specificity of anti-Scl-70 antibodies in scleroderma: increased sensitivity of detection using purified DNA topoisomerase I from calf thymus.
Tsay GJ; Fann RH; Hwang J
J Rheumatol; 1990 Oct; 17(10):1314-9. PubMed ID: 2174971
[TBL] [Abstract][Full Text] [Related]
2. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).
Shoenfeld Y; Grunebaum E; Laufer M; Zurgil N; Bakimer R; Lunderschmidt A; Valentini G; Tirri G; Blank M
Isr J Med Sci; 1996 Jul; 32(7):537-42. PubMed ID: 8756980
[TBL] [Abstract][Full Text] [Related]
3. Scl-86, a marker antigen for diffuse scleroderma.
van Venrooij WJ; Stapel SO; Houben H; Habets WJ; Kallenberg CG; Penner E; van de Putte LB
J Clin Invest; 1985 Mar; 75(3):1053-60. PubMed ID: 3980727
[TBL] [Abstract][Full Text] [Related]
4. Anti-topoisomerase I autoantibodies in systemic sclerosis.
Czömpöly T; Simon D; Czirják L; Németh P
Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to topoisomerase I in sera from patients with scleroderma.
Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():138-40. PubMed ID: 3039129
[TBL] [Abstract][Full Text] [Related]
6. [Antibodies against topoisomerase I (Scl-70)--comparative studies on detection with recombinant protein antigens and natural enzyme].
Seelig HP; Schröter H; Ehrfeld H; Renz M
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):505-11. PubMed ID: 7856253
[No Abstract] [Full Text] [Related]
7. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
[TBL] [Abstract][Full Text] [Related]
8. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
9. [Anti-idiotypic antibodies to topoisomerase I in serum from patients with autoimmune diseases].
Bronshteĭn IB; Shuster AM; Gromova II; Krashuk OA; Geva ON; Alekberova ZS; Gabibov AG
Dokl Akad Nauk SSSR; 1991; 318(6):1496-500. PubMed ID: 1655373
[No Abstract] [Full Text] [Related]
10. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus.
Gussin HA; Ignat GP; Varga J; Teodorescu M
Arthritis Rheum; 2001 Feb; 44(2):376-83. PubMed ID: 11229469
[TBL] [Abstract][Full Text] [Related]
11. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
Hénault J; Robitaille G; Senécal JL; Raymond Y
Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
[TBL] [Abstract][Full Text] [Related]
12. Scl-70 antigen stability and its effect on antibody detection in scleroderma.
Kumar V; Kowalewski C; Koelle M; Qutaishat S; Chorzelski TP; Beutner EH; Jarzabek-Chorzelska M; Kolacinska Z; Jablonska S
J Rheumatol; 1988 Oct; 15(10):1499-502. PubMed ID: 3144599
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay.
Hildebrandt S; Weiner ES; Senecal JL; Noell GS; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1990 Dec; 57(3):399-410. PubMed ID: 2173985
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
15. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
Mahler M; Fritzler MJ
Autoimmun Rev; 2009 Mar; 8(5):373-8. PubMed ID: 19103309
[TBL] [Abstract][Full Text] [Related]
16. Anti-scl-70.
Basu D; Reveille JD
Autoimmunity; 2005 Feb; 38(1):65-72. PubMed ID: 15804707
[TBL] [Abstract][Full Text] [Related]
17. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
18. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
[TBL] [Abstract][Full Text] [Related]
19. [The clinical significance of detecting the inhibition of topoisomerase I by the sera of patients with systemic scleroderma].
Shcherbakov AB; Remenson EI; Kirsanova ID; Basnak'ian AG; Guseva NG
Ter Arkh; 1992; 64(5):73-5. PubMed ID: 1333647
[TBL] [Abstract][Full Text] [Related]
20. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
Henry PA; Atamas SP; Yurovsky VV; Luzina I; Wigley FM; White B
Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
